Pin Oak Investment Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History

Pin Oak Investment Advisors’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-22	Closed	-$10K	–	422
2021 Q1	$10K	Sell	22 -364	-94%	-$177K	0.01%	321
2020 Q4	$186K	Hold	386	–	–	0.15%	103
2020 Q3	$216K	Hold	386	–	–	0.21%	90
2020 Q2	$241K	Hold	386	–	–	0.22%	84
2020 Q1	$188K	Buy	386 +9	+2%	+$3.71K	0.2%	95
2019 Q4	$142K	Sell	377 -38	-9%	-$12.8K	0.11%	121
2019 Q3	$115K	Hold	415	–	–	0.09%	141
2019 Q2	$130K	Hold	415	–	–	0.1%	136
2019 Q1	$170K	Buy	415 +23	+6%	+$9.47K	0.14%	121
2018 Q4	$146K	Hold	392	–	–	0.13%	122
2018 Q3	$158K	Buy	392 +1	+0.3%	+$381	0.12%	128
2018 Q2	$135K	Sell	391 -14	-3%	-$4.38K	0.1%	133
2018 Q1	$139K	Buy	405 +1	+0.2%	+$348	0.11%	131
2017 Q4	$152K	Buy	+404	New	+$164K	0.12%	130

Other funds holding REGN

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Pin Oak Investment Advisors's REGN Position: Q2 2021 in Review

Pin Oak Investment Advisors sold out of Regeneron Pharmaceuticals (REGN) in Q2 2021, closing a stake of 22 shares — an estimated $10K sold.

Pin Oak Investment Advisors first reported a position in REGN in Q4 2017 and held it in 14 quarters. The position peaked at $241K in Q2 2020. 971 funds tracked by Wall St. Rank hold REGN as of Q2 2021.

Pin Oak Investment Advisors reported no remaining Regeneron Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
Pin Oak Investment Advisors sold 22 Regeneron Pharmaceuticals shares in Q2 2021, an estimated $10K.
Pin Oak Investment Advisors first reported a position in Regeneron Pharmaceuticals in Q4 2017 and held it in 14 quarters.
Pin Oak Investment Advisors's Regeneron Pharmaceuticals position peaked at $241K in Q2 2020.
971 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2021.

Based on Pin Oak Investment Advisors's 13F filing for Q2 2021, filed 16 Aug 2021.